Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats
- PMID: 20670429
- PMCID: PMC2927592
- DOI: 10.1186/1476-511X-9-81
Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats
Abstract
Background: The metabolic syndrome, known also as the insulin resistance syndrome, refers to the clustering of several risk factors for atherosclerotic cardiovascular disease. Dyslipidaemia is a hallmark of the syndrome and is associated with a whole body reduction in the activity of lipoprotein lipase (LPL), an enzyme under the regulation of the class of nuclear receptors known as peroxisome proliferator-activated receptor (PPAR). Glycyrrhizic acid (GA), a triterpenoid saponin, is the primary bioactive constituent of the roots of the shrub Glycyrrhiza glabra. Studies have indicated that triterpenoids could act as PPAR agonists and GA is therefore postulated to restore LPL expression in the insulin resistant state.
Results: Oral administration of 100 mg/kg of GA to high-fat diet-induced obese rats for 28 days led to significant reduction in blood glucose concentration and improvement in insulin sensitivity as indicated by the homeostasis model assessment of insulin resistance (HOMA-IR) (p < 0.05). LPL expression was up-regulated in the kidney, heart, quadriceps femoris, abdominal muscle and the visceral and subcutaneous adipose tissues but down-regulated in the liver--a condition in reverse to that seen in high-fat diet-induced obese rats without GA. With regard to lipid metabolism, GA administration led to significant hypotriglyceridemic and HDL-raising effects (p < 0.05), with a consistent reduction in serum free fatty acid, total cholesterol and LDL cholesterol and significant decrease in tissue lipid deposition across all studied tissue (p < 0.01).
Conclusion: In conclusion, GA may be a potential compound in improving dyslipidaemia by selectively inducing LPL expression in non-hepatic tissues. Such up-regulation was accompanied by a GA-mediated improvement in insulin sensitivity, which may be associated with a decrease in tissue lipid deposition. The HDL-raising effect of GA suggests the antiatherosclerotic properties of GA.
Figures
Similar articles
-
Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats.Lipids Health Dis. 2009 Jul 29;8:31. doi: 10.1186/1476-511X-8-31. Lipids Health Dis. 2009. PMID: 19638239 Free PMC article.
-
Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats.PPAR Res. 2010;2010:530265. doi: 10.1155/2010/530265. PPAR Res. 2010. PMID: 20011054 Free PMC article.
-
Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.Biomed Pharmacother. 2019 Sep;117:109176. doi: 10.1016/j.biopha.2019.109176. Epub 2019 Jul 1. Biomed Pharmacother. 2019. PMID: 31387185
-
PPAR Agonists and Metabolic Syndrome: An Established Role?Int J Mol Sci. 2018 Apr 14;19(4):1197. doi: 10.3390/ijms19041197. Int J Mol Sci. 2018. PMID: 29662003 Free PMC article. Review.
-
Lipoprotein lipase and atherosclerosis.Curr Vasc Pharmacol. 2003 Mar;1(1):11-7. doi: 10.2174/1570161033386673. Curr Vasc Pharmacol. 2003. PMID: 15320848 Review.
Cited by
-
Identification of TonB-dependent siderophore receptor inhibitors against Flavobacterium columnare using a structure-based high-throughput virtual screening method.Front Microbiol. 2024 May 21;15:1392178. doi: 10.3389/fmicb.2024.1392178. eCollection 2024. Front Microbiol. 2024. PMID: 38835482 Free PMC article.
-
Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis.Acta Diabetol. 2024 Aug;61(8):1053-1068. doi: 10.1007/s00592-024-02278-1. Epub 2024 May 1. Acta Diabetol. 2024. PMID: 38691241
-
The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model.Front Pharmacol. 2024 Jan 23;15:1260603. doi: 10.3389/fphar.2024.1260603. eCollection 2024. Front Pharmacol. 2024. PMID: 38323083 Free PMC article.
-
Integrating Metabolomics and Network Pharmacology to Decipher the Hepatoprotective Effect Mechanisms of Magnesium Isoglycyrrhizinate Injection.Curr Issues Mol Biol. 2023 Dec 29;46(1):279-298. doi: 10.3390/cimb46010019. Curr Issues Mol Biol. 2023. PMID: 38248321 Free PMC article.
-
Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications.Int J Mol Sci. 2022 Sep 20;23(19):10988. doi: 10.3390/ijms231910988. Int J Mol Sci. 2022. PMID: 36232291 Free PMC article. Review.
References
-
- Janus E. Metabolic syndrome and its relevance to Asia. International Congress Series. 2004;1262:535–537. doi: 10.1016/S0531-5131(03)01834-X. - DOI
-
- Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in the skeletal muscle is related to insulin sensitivity. Arterioscler Thromb Vasc Biol. 1991;11:1192–1203. - PubMed
-
- Kageyama H, Hirano T, Okada K, Ebara T, Kageyama A, Murakami T, Shioda S, Adachi M. Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma. Biochem Biophys Res Commun. 2003;305:22–27. doi: 10.1016/S0006-291X(03)00663-6. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
